Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study
•Patients with breast cancer and doxorubicin-based chemotherapy present a hypercoagulable state.•Thrombin generation showed changes in patients using doxorubicin according to cardiotoxicity.•Thrombin generation parameters may be useful in monitoring hemostasis in these patients.
Gespeichert in:
| Veröffentlicht in: | Thrombosis research 2022-03, Vol.211, p.56-59 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 59 |
|---|---|
| container_issue | |
| container_start_page | 56 |
| container_title | Thrombosis research |
| container_volume | 211 |
| creator | Pestana, Rodrigo M.C. Duarte, Rita C.F. Alves, Michelle T. de Oliveira, Angélica N. Oliveira, Heloísa H.M. Soares, Cintia E. de P. Sabino, Adriano Silva, Luciana M. das Graças Carvalho, Maria Simões, Ricardo Gomes, Karina B. |
| description | •Patients with breast cancer and doxorubicin-based chemotherapy present a hypercoagulable state.•Thrombin generation showed changes in patients using doxorubicin according to cardiotoxicity.•Thrombin generation parameters may be useful in monitoring hemostasis in these patients. |
| doi_str_mv | 10.1016/j.thromres.2022.01.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2622657059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384822000093</els_id><sourcerecordid>2622657059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-58497be8e389d283edf7d84b6ff45f51ddb837fd9ad2faef29a9ff7d04a6fcc43</originalsourceid><addsrcrecordid>eNqFkcFu3CAQhlHVqtmkfYWIYy52AGMbbomitokUqZf2jDAMWla22QJO4lsfoLe-YZ8krDbJtRcGDd_ML_4foXNKakpod7mr8zaGKUKqGWGsJrQmRL5DGyp6WTHes_doQwiXVSO4OEGnKe0IoT2V7Ud00rSk5x0lG_TnFqaQss7e4ENZEvYzfgwTlNPnLR4i6JSx0bOBiPVsyzVaH3J48sbnFeuUgvE6g8U5YBueQlyG8jRXg06labZFIW8h6v2K__3-i69xmKFaQUfswjiGx2rZF-3Frp_QB6fHBJ9f6hn6-fXLj5vb6v77t7ub6_vKNJ3IVSu47AcQ0AhpmWjAut4KPnTO8da11NpBNL2zUlvmNDgmtXQFIVx3zhjenKGL4959DL8WSFlNPhkYRz1DWJJiHWNd25NWFrQ7oiaGlCI4tY9-0nFVlKhDEmqnXpNQhyQUoaokUQbPXzSWYQL7NvZqfQGujgCUnz54iCoZD8Vl6yOYrGzw_9N4Bgoao4k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622657059</pqid></control><display><type>article</type><title>Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Pestana, Rodrigo M.C. ; Duarte, Rita C.F. ; Alves, Michelle T. ; de Oliveira, Angélica N. ; Oliveira, Heloísa H.M. ; Soares, Cintia E. ; de P. Sabino, Adriano ; Silva, Luciana M. ; das Graças Carvalho, Maria ; Simões, Ricardo ; Gomes, Karina B.</creator><creatorcontrib>Pestana, Rodrigo M.C. ; Duarte, Rita C.F. ; Alves, Michelle T. ; de Oliveira, Angélica N. ; Oliveira, Heloísa H.M. ; Soares, Cintia E. ; de P. Sabino, Adriano ; Silva, Luciana M. ; das Graças Carvalho, Maria ; Simões, Ricardo ; Gomes, Karina B.</creatorcontrib><description>•Patients with breast cancer and doxorubicin-based chemotherapy present a hypercoagulable state.•Thrombin generation showed changes in patients using doxorubicin according to cardiotoxicity.•Thrombin generation parameters may be useful in monitoring hemostasis in these patients.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2022.01.009</identifier><identifier>PMID: 35074610</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Antineoplastic Combined Chemotherapy Protocols ; Breast cancer ; Breast Neoplasms - drug therapy ; Cardiotoxicity ; Cardiotoxicity - etiology ; Doxorubicin ; Doxorubicin - adverse effects ; Female ; Follow-Up Studies ; Hemostasis ; Hemostatics - therapeutic use ; Humans ; Thrombin generation</subject><ispartof>Thrombosis research, 2022-03, Vol.211, p.56-59</ispartof><rights>2022 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-58497be8e389d283edf7d84b6ff45f51ddb837fd9ad2faef29a9ff7d04a6fcc43</citedby><cites>FETCH-LOGICAL-c368t-58497be8e389d283edf7d84b6ff45f51ddb837fd9ad2faef29a9ff7d04a6fcc43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0049384822000093$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35074610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pestana, Rodrigo M.C.</creatorcontrib><creatorcontrib>Duarte, Rita C.F.</creatorcontrib><creatorcontrib>Alves, Michelle T.</creatorcontrib><creatorcontrib>de Oliveira, Angélica N.</creatorcontrib><creatorcontrib>Oliveira, Heloísa H.M.</creatorcontrib><creatorcontrib>Soares, Cintia E.</creatorcontrib><creatorcontrib>de P. Sabino, Adriano</creatorcontrib><creatorcontrib>Silva, Luciana M.</creatorcontrib><creatorcontrib>das Graças Carvalho, Maria</creatorcontrib><creatorcontrib>Simões, Ricardo</creatorcontrib><creatorcontrib>Gomes, Karina B.</creatorcontrib><title>Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>•Patients with breast cancer and doxorubicin-based chemotherapy present a hypercoagulable state.•Thrombin generation showed changes in patients using doxorubicin according to cardiotoxicity.•Thrombin generation parameters may be useful in monitoring hemostasis in these patients.</description><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Cardiotoxicity</subject><subject>Cardiotoxicity - etiology</subject><subject>Doxorubicin</subject><subject>Doxorubicin - adverse effects</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hemostasis</subject><subject>Hemostatics - therapeutic use</subject><subject>Humans</subject><subject>Thrombin generation</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu3CAQhlHVqtmkfYWIYy52AGMbbomitokUqZf2jDAMWla22QJO4lsfoLe-YZ8krDbJtRcGDd_ML_4foXNKakpod7mr8zaGKUKqGWGsJrQmRL5DGyp6WTHes_doQwiXVSO4OEGnKe0IoT2V7Ud00rSk5x0lG_TnFqaQss7e4ENZEvYzfgwTlNPnLR4i6JSx0bOBiPVsyzVaH3J48sbnFeuUgvE6g8U5YBueQlyG8jRXg06labZFIW8h6v2K__3-i69xmKFaQUfswjiGx2rZF-3Frp_QB6fHBJ9f6hn6-fXLj5vb6v77t7ub6_vKNJ3IVSu47AcQ0AhpmWjAut4KPnTO8da11NpBNL2zUlvmNDgmtXQFIVx3zhjenKGL4959DL8WSFlNPhkYRz1DWJJiHWNd25NWFrQ7oiaGlCI4tY9-0nFVlKhDEmqnXpNQhyQUoaokUQbPXzSWYQL7NvZqfQGujgCUnz54iCoZD8Vl6yOYrGzw_9N4Bgoao4k</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Pestana, Rodrigo M.C.</creator><creator>Duarte, Rita C.F.</creator><creator>Alves, Michelle T.</creator><creator>de Oliveira, Angélica N.</creator><creator>Oliveira, Heloísa H.M.</creator><creator>Soares, Cintia E.</creator><creator>de P. Sabino, Adriano</creator><creator>Silva, Luciana M.</creator><creator>das Graças Carvalho, Maria</creator><creator>Simões, Ricardo</creator><creator>Gomes, Karina B.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202203</creationdate><title>Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study</title><author>Pestana, Rodrigo M.C. ; Duarte, Rita C.F. ; Alves, Michelle T. ; de Oliveira, Angélica N. ; Oliveira, Heloísa H.M. ; Soares, Cintia E. ; de P. Sabino, Adriano ; Silva, Luciana M. ; das Graças Carvalho, Maria ; Simões, Ricardo ; Gomes, Karina B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-58497be8e389d283edf7d84b6ff45f51ddb837fd9ad2faef29a9ff7d04a6fcc43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Cardiotoxicity</topic><topic>Cardiotoxicity - etiology</topic><topic>Doxorubicin</topic><topic>Doxorubicin - adverse effects</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hemostasis</topic><topic>Hemostatics - therapeutic use</topic><topic>Humans</topic><topic>Thrombin generation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pestana, Rodrigo M.C.</creatorcontrib><creatorcontrib>Duarte, Rita C.F.</creatorcontrib><creatorcontrib>Alves, Michelle T.</creatorcontrib><creatorcontrib>de Oliveira, Angélica N.</creatorcontrib><creatorcontrib>Oliveira, Heloísa H.M.</creatorcontrib><creatorcontrib>Soares, Cintia E.</creatorcontrib><creatorcontrib>de P. Sabino, Adriano</creatorcontrib><creatorcontrib>Silva, Luciana M.</creatorcontrib><creatorcontrib>das Graças Carvalho, Maria</creatorcontrib><creatorcontrib>Simões, Ricardo</creatorcontrib><creatorcontrib>Gomes, Karina B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pestana, Rodrigo M.C.</au><au>Duarte, Rita C.F.</au><au>Alves, Michelle T.</au><au>de Oliveira, Angélica N.</au><au>Oliveira, Heloísa H.M.</au><au>Soares, Cintia E.</au><au>de P. Sabino, Adriano</au><au>Silva, Luciana M.</au><au>das Graças Carvalho, Maria</au><au>Simões, Ricardo</au><au>Gomes, Karina B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2022-03</date><risdate>2022</risdate><volume>211</volume><spage>56</spage><epage>59</epage><pages>56-59</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>•Patients with breast cancer and doxorubicin-based chemotherapy present a hypercoagulable state.•Thrombin generation showed changes in patients using doxorubicin according to cardiotoxicity.•Thrombin generation parameters may be useful in monitoring hemostasis in these patients.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>35074610</pmid><doi>10.1016/j.thromres.2022.01.009</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0049-3848 |
| ispartof | Thrombosis research, 2022-03, Vol.211, p.56-59 |
| issn | 0049-3848 1879-2472 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2622657059 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Antineoplastic Combined Chemotherapy Protocols Breast cancer Breast Neoplasms - drug therapy Cardiotoxicity Cardiotoxicity - etiology Doxorubicin Doxorubicin - adverse effects Female Follow-Up Studies Hemostasis Hemostatics - therapeutic use Humans Thrombin generation |
| title | Hemostatic status in women with breast cancer and cardiotoxicity associated to doxorubicin-based chemotherapy – A one-year follow-up study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T20%3A08%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemostatic%20status%20in%20women%20with%20breast%20cancer%20and%20cardiotoxicity%20associated%20to%20doxorubicin-based%20chemotherapy%20%E2%80%93%20A%20one-year%20follow-up%20study&rft.jtitle=Thrombosis%20research&rft.au=Pestana,%20Rodrigo%20M.C.&rft.date=2022-03&rft.volume=211&rft.spage=56&rft.epage=59&rft.pages=56-59&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2022.01.009&rft_dat=%3Cproquest_cross%3E2622657059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622657059&rft_id=info:pmid/35074610&rft_els_id=S0049384822000093&rfr_iscdi=true |